ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,296.00
-0.41%
S&P ASX All Technology
3,854.60
-0.04%
Brent Oil
74.135
0.00%
US Dollar vs AUD
1.57257
-0.09%
Bitcoin
101,743.21
0.28%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Photocure Asa (0IMT)

  7. Photocure Asa (0IMT) News

0IMT

Photocure Asa (0IMT)

Photocure Asa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0IMT
DateTimeSourceHeadlineSymbolCompany
09/08/202316:30PR Newswire (US)Photocure ASA: Results for the second quarter and first half of 2023LSE:0IMTPhotocure Asa
09/08/202316:26PR Newswire (US)Photocure ASA: Results for the second quarter and first half of 2023LSE:0IMTPhotocure Asa
06/07/202318:57PR Newswire (US)Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in ChinaLSE:0IMTPhotocure Asa
06/07/202318:54PR Newswire (US)Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in ChinaLSE:0IMTPhotocure Asa
10/05/202316:18PR Newswire (US)Photocure ASA: Results for the first quarter of 2023LSE:0IMTPhotocure Asa
10/05/202316:15PR Newswire (US)Photocure ASA: Results for the first quarter of 2023LSE:0IMTPhotocure Asa
04/05/202321:48PR Newswire (US)Photocure ASA - Correction: Annual general meeting heldLSE:0IMTPhotocure Asa
04/05/202321:44PR Newswire (US)Photocure ASA - Correction: Annual general meeting heldLSE:0IMTPhotocure Asa
04/05/202302:58PR Newswire (US)Photocure ASA - Annual general meeting heldLSE:0IMTPhotocure Asa
04/05/202302:53PR Newswire (US)Photocure ASA - Annual general meeting heldLSE:0IMTPhotocure Asa
03/05/202319:53PR Newswire (US)Photocure ASA: Invitation to presentation of first quarter 2023 financial resultsLSE:0IMTPhotocure Asa
03/05/202319:52PR Newswire (US)Photocure ASA: Invitation to presentation of first quarter 2023 financial resultsLSE:0IMTPhotocure Asa
03/05/202301:35PR Newswire (US)Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light CystoscopyLSE:0IMTPhotocure Asa
03/05/202301:30PR Newswire (US)Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light CystoscopyLSE:0IMTPhotocure Asa
13/04/202300:14PR Newswire (US)Photocure ASA: Annual Report 2022LSE:0IMTPhotocure Asa
13/04/202300:14PR Newswire (US)Photocure ASA - Notice of the Annual General Meeting 3 May 2023LSE:0IMTPhotocure Asa
13/04/202300:12PR Newswire (US)Photocure ASA - Notice of the Annual General Meeting 3 May 2023LSE:0IMTPhotocure Asa
13/04/202300:11PR Newswire (US)Photocure ASA: Annual Report 2022LSE:0IMTPhotocure Asa
14/03/202318:53PR Newswire (US)Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancerLSE:0IMTPhotocure Asa
14/03/202318:40PR Newswire (US)Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancerLSE:0IMTPhotocure Asa
23/02/202318:29PR Newswire (US)Photocure ASA: Results for the fourth quarter of 2022LSE:0IMTPhotocure Asa
23/02/202318:27PR Newswire (US)Photocure ASA: Results for the fourth quarter of 2022LSE:0IMTPhotocure Asa
20/02/202317:43PR Newswire (US)Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLCLSE:0IMTPhotocure Asa
03/01/202317:47PR Newswire (US)New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursementLSE:0IMTPhotocure Asa
03/01/202317:45PR Newswire (US)New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursementLSE:0IMTPhotocure Asa
05/12/202218:08PR Newswire (US)New Evidence: Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO MeetingLSE:0IMTPhotocure Asa
05/12/202218:03PR Newswire (US)New Evidence: Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO MeetingLSE:0IMTPhotocure Asa
07/11/202218:11PR Newswire (US)Photocure: CMS improves Medicare reimbursement for Blue Light Cystoscopy with Cysview and expands access in the surveillance settingLSE:0IMTPhotocure Asa
02/11/202218:38PR Newswire (US)Photocure ASA: Results for the third quarter of 2022LSE:0IMTPhotocure Asa
02/11/202218:37PR Newswire (US)Photocure ASA: Results for the third quarter of 2022LSE:0IMTPhotocure Asa
 Showing the most relevant articles for your search:LSE:0IMT

Your Recent History

ASX
AMP
AMP
ASX
WOW
Woolworths
NASDAQ
TSLA
Tesla
ASX
WPL
Woodside Petroleum
ASX
BHP
BHP
ASX
XJO
S&P ASX 200
SPI
SP500
S&P 500
ASX
CSL
CSL
ASX
ORG
Origin Energy
ASX
XFL
S&P ASX 50
FX
AUDUSD
AUD vs US Dollar
CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
NASDAQ
MSFT
Microsoft
ASX
XAO
Australian SE All Ordina...
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved